S&P 500   4,594.63
DOW   36,245.50
QQQ   389.94
Man kills 4 relatives in Queens knife rampage, injures 2 officers before he's fatally shot by police
New CBOE “special perk” helps traders target income every weekend (Ad)
British military reports an explosion off the coast of Yemen in the key Bab el-Mandeb Strait
Lacking counselors, US schools turn to the booming business of online therapy
New CBOE “special perk” helps traders target income every weekend (Ad)
Kiss say farewell to live touring, become first US band to go virtual and become digital avatars
Chinese developer Evergrande risking liquidation if creditors veto its plan for handling huge debts
New CBOE “special perk” helps traders target income every weekend (Ad)
Alaska Air to buy Hawaiian Airlines in a $1.9 billion deal that may attract regulator scrutiny
Watchdog: Western arms companies failed to ramp up production capacity in 2022 due to Ukraine war
S&P 500   4,594.63
DOW   36,245.50
QQQ   389.94
Man kills 4 relatives in Queens knife rampage, injures 2 officers before he's fatally shot by police
New CBOE “special perk” helps traders target income every weekend (Ad)
British military reports an explosion off the coast of Yemen in the key Bab el-Mandeb Strait
Lacking counselors, US schools turn to the booming business of online therapy
New CBOE “special perk” helps traders target income every weekend (Ad)
Kiss say farewell to live touring, become first US band to go virtual and become digital avatars
Chinese developer Evergrande risking liquidation if creditors veto its plan for handling huge debts
New CBOE “special perk” helps traders target income every weekend (Ad)
Alaska Air to buy Hawaiian Airlines in a $1.9 billion deal that may attract regulator scrutiny
Watchdog: Western arms companies failed to ramp up production capacity in 2022 due to Ukraine war
S&P 500   4,594.63
DOW   36,245.50
QQQ   389.94
Man kills 4 relatives in Queens knife rampage, injures 2 officers before he's fatally shot by police
New CBOE “special perk” helps traders target income every weekend (Ad)
British military reports an explosion off the coast of Yemen in the key Bab el-Mandeb Strait
Lacking counselors, US schools turn to the booming business of online therapy
New CBOE “special perk” helps traders target income every weekend (Ad)
Kiss say farewell to live touring, become first US band to go virtual and become digital avatars
Chinese developer Evergrande risking liquidation if creditors veto its plan for handling huge debts
New CBOE “special perk” helps traders target income every weekend (Ad)
Alaska Air to buy Hawaiian Airlines in a $1.9 billion deal that may attract regulator scrutiny
Watchdog: Western arms companies failed to ramp up production capacity in 2022 due to Ukraine war
S&P 500   4,594.63
DOW   36,245.50
QQQ   389.94
Man kills 4 relatives in Queens knife rampage, injures 2 officers before he's fatally shot by police
New CBOE “special perk” helps traders target income every weekend (Ad)
British military reports an explosion off the coast of Yemen in the key Bab el-Mandeb Strait
Lacking counselors, US schools turn to the booming business of online therapy
New CBOE “special perk” helps traders target income every weekend (Ad)
Kiss say farewell to live touring, become first US band to go virtual and become digital avatars
Chinese developer Evergrande risking liquidation if creditors veto its plan for handling huge debts
New CBOE “special perk” helps traders target income every weekend (Ad)
Alaska Air to buy Hawaiian Airlines in a $1.9 billion deal that may attract regulator scrutiny
Watchdog: Western arms companies failed to ramp up production capacity in 2022 due to Ukraine war

Eledon Pharmaceuticals (ELDN) News Today

$1.14
-0.01 (-0.87%)
(As of 12/1/2023 ET)
Compare
Today's Range
$1.12
$1.16
50-Day Range
$1.12
$1.69
52-Week Range
$1.07
$3.70
Volume
38,488 shs
Average Volume
58,054 shs
Market Capitalization
$27.59 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$10.67
SourceHeadline
finance.yahoo.com logoEledon Pharmaceuticals to Present at Noble Capital Markets' Emerging Growth Equity Conference
finance.yahoo.com - November 29 at 7:23 PM
finanznachrichten.de logoEledon Pharmaceuticals, Inc.: Eledon Pharmaceuticals Reports Third Quarter 2023 Operating and Financial Results
finanznachrichten.de - November 10 at 7:37 AM
msn.com logoEledon Pharmaceuticals, Inc. (ELDN) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?
msn.com - November 9 at 4:28 PM
finance.yahoo.com logoEledon Pharmaceuticals Reports Third Quarter 2023 Operating and Financial Results
finance.yahoo.com - November 9 at 4:28 PM
finance.yahoo.com logoEledon Pharmaceuticals to Present at Jefferies London Healthcare Conference
finance.yahoo.com - November 8 at 7:22 PM
markets.businessinsider.com logoPromising Results and Buy Rating for Eledon Pharmaceuticals: Tegoprubart’s Potential in Kidney Transplant Therapy
markets.businessinsider.com - November 6 at 6:54 PM
markets.businessinsider.com logoPromising Phase Ib Study Results Bolster Buy Rating for Eledon Pharmaceuticals: An Analysis by Rami Katkhuda
markets.businessinsider.com - November 4 at 8:55 AM
finance.yahoo.com logoEledon Reports Updated Data from Ongoing Phase 1b Trial Evaluating Tegoprubart for Prevention of Rejection in Kidney Transplantation
finance.yahoo.com - November 2 at 1:53 PM
msn.com logoHC Wainwright & Co. Maintains Eledon Pharmaceuticals (ELDN) Buy Recommendation
msn.com - October 24 at 7:00 PM
msn.com logoEledon Pharmaceuticals appoints Eliezer Katz as CMO
msn.com - October 23 at 9:00 AM
markets.businessinsider.com logoEledon Pharmaceuticals Appoints Eliezer Katz As Chief Medical Officer
markets.businessinsider.com - October 23 at 9:00 AM
finance.yahoo.com logoEledon Pharmaceuticals Strengthens Leadership Team with Appointment of Eliezer Katz, M.D., FACS as Chief Medical Officer
finance.yahoo.com - October 23 at 9:00 AM
finance.yahoo.com logoEledon Pharmaceuticals to Present Data from Ongoing Phase 1b Trial of Tegoprubart in Patients Undergoing Kidney Transplantation at the American Society of Nephrology Kidney Week 2023 Annual Meeting
finance.yahoo.com - October 13 at 9:59 AM
finance.yahoo.com logoEledon Pharmaceuticals Appoints Kidney Transplant Specialist Dr. Allan Douglas Kirk to Board of Directors
finance.yahoo.com - October 2 at 8:12 AM
nasdaq.com logoNoble Capital Markets Initiates Coverage of Eledon Pharmaceuticals (ELDN) with Outperform Recommendation
nasdaq.com - September 28 at 12:26 AM
markets.businessinsider.com logoPromising Clinical Trials and Future Projections Bolster Buy Rating for Eledon Pharmaceuticals
markets.businessinsider.com - September 27 at 9:24 AM
finance.yahoo.com logoEledon Pharmaceuticals Announces Use of Tegoprubart anti-CD40L Antibody in Second-ever Transplant of Genetically Modified Heart from a Pig to a Human
finance.yahoo.com - September 25 at 7:58 AM
finance.yahoo.com logoEledon Pharmaceuticals to Participate at the 2023 Cantor Fitzgerald Global Healthcare Conference
finance.yahoo.com - September 20 at 8:16 PM
finance.yahoo.com logoEledon Pharmaceuticals Announces Publication of Data Showing Treatment with Tegoprubart Promotes Kidney and Islet Allograft Survival and Function in Nonhuman Primates
finance.yahoo.com - September 6 at 11:52 AM
finance.yahoo.com logoEledon Pharmaceuticals Announces First Participant Dosed in Phase 2 BESTOW Trial Evaluating Tegoprubart for the Prevention of Rejection in Kidney Transplantation
finance.yahoo.com - September 5 at 11:44 AM
msn.com logoCantor Fitzgerald Reiterates Eledon Pharmaceuticals (ELDN) Overweight Recommendation
msn.com - August 22 at 4:40 PM
finance.yahoo.com logoEledon Pharmaceuticals Announces Dosing of 10th Patient in Ongoing Phase 1b Trial Evaluating Tegoprubart in Patients Undergoing Kidney Transplantation
finance.yahoo.com - August 16 at 1:50 PM
finance.yahoo.com logoEledon Pharmaceuticals Reports Second Quarter 2023 Operating and Financial Results
finance.yahoo.com - August 10 at 8:22 AM
finance.yahoo.com logoIs Eledon Pharmaceuticals (NASDAQ:ELDN) In A Good Position To Deliver On Growth Plans?
finance.yahoo.com - July 17 at 2:09 PM
finance.yahoo.com logoAmerigo Reports Q2-2023 Production Results and Provides MVC Operational Update
finance.yahoo.com - July 12 at 8:01 AM
markets.businessinsider.com logoSVB Securities Reaffirms Their Buy Rating on Eledon Pharmaceuticals (ELDN)
markets.businessinsider.com - June 3 at 10:41 AM
finance.yahoo.com logoEledon Pharmaceuticals to Present at Jefferies Healthcare Conference
finance.yahoo.com - June 2 at 9:25 AM
msn.com logoEledon Pharmaceuticals GAAP EPS of -$0.75 misses by $0.11
msn.com - May 11 at 7:45 PM
finance.yahoo.com logoEledon Pharmaceuticals Reports First Quarter 2023 Operating and Financial Results
finance.yahoo.com - May 11 at 7:45 PM
msn.com logoEledon Pharmaceuticals: Disrupting The Kidney Transplantation Landscape
msn.com - May 10 at 6:41 PM
finance.yahoo.com logoEledon Pharmaceuticals to Report First Quarter 2023 Financial Results on Thursday, May 11, 2023
finance.yahoo.com - May 4 at 5:02 PM
msn.com logoEledon stock rises ~10% after up to $185M financing
msn.com - May 1 at 10:58 AM
finance.yahoo.com logoEledon Pharmaceuticals Announces up to $185 Million Financing to Advance Tegoprubart Kidney Transplantation Clinical Trials
finance.yahoo.com - May 1 at 10:58 AM
finance.yahoo.com logoEledon Pharmaceuticals, Inc. (NASDAQ:ELDN) Q4 2022 Earnings Call Transcript
finance.yahoo.com - April 6 at 12:39 AM
finanznachrichten.de logoEledon Pharmaceuticals, Inc.: Eledon Pharmaceuticals Reports Fourth Quarter and Full-Year 2022 Operating and Financial Results
finanznachrichten.de - April 1 at 1:56 AM
markets.businessinsider.com logoAnalysts Offer Insights on Healthcare Companies: Amgen (AMGN) and Eledon Pharmaceuticals (ELDN)
markets.businessinsider.com - March 31 at 10:52 AM
msn.com logoEledon tegoprubart shows promise in kidney transplant patients in phase 1b trial
msn.com - March 31 at 10:52 AM
finance.yahoo.com logoEledon Reports Data from Ongoing Phase 1b Trial Evaluating Tegoprubart in Patients Undergoing Kidney Transplantation at World Congress of Nephrology
finance.yahoo.com - March 31 at 10:52 AM
finance.yahoo.com logoEledon Pharmaceuticals Reports Fourth Quarter and Full-Year 2022 Operating and Financial Results
finance.yahoo.com - March 30 at 6:31 PM
msn.com logoEledon Pharmaceuticals's Earnings: A Preview
msn.com - March 29 at 5:28 PM
markets.businessinsider.com logoAnalysts Offer Insights on Healthcare Companies: Crispr Therapeutics AG (CRSP), Eledon Pharmaceuticals (ELDN) and Celcuity (CELC)
markets.businessinsider.com - March 28 at 8:30 AM
finance.yahoo.com logoEledon Pharmaceuticals to Report Fourth Quarter and Full Year 2022 Financial Results on Thursday, March 30, 2023
finance.yahoo.com - March 23 at 5:43 PM
finance.yahoo.com logoEledon to Present Data from Ongoing Phase 1b Trial Evaluating Tegoprubart in Kidney Transplantation at the World Congress of Nephrology 2023
finance.yahoo.com - March 23 at 12:42 PM
finance.yahoo.com logoEledon Pharmaceuticals to Present at SVB Securities Global Biopharma Conference
finance.yahoo.com - February 8 at 6:24 PM
finance.yahoo.com logoeGenesis and Eledon Pharmaceuticals Announce Collaboration for Use of Tegoprubart in Preclinical Xenotransplantation Studies
finance.yahoo.com - January 9 at 9:17 AM
finance.yahoo.com logoEledon Pharmaceuticals Provides Business and Pipeline Updates
finance.yahoo.com - January 9 at 9:17 AM
finance.yahoo.com logoC-Path's Transplant Therapeutics Consortium Receives EMA Qualification Opinion for iBox Scoring System
finance.yahoo.com - December 21 at 7:47 PM
finanznachrichten.de logoEledon Pharmaceuticals, Inc.: Eledon Pharmaceuticals Reports Third Quarter 2022 Operating and Financial Results
finanznachrichten.de - December 1 at 3:38 PM
seekingalpha.com logoEledon Pharmaceuticals, Inc. (ELDN) Q3 2022 Earnings Call Transcript
seekingalpha.com - November 15 at 4:40 AM
finance.yahoo.com logoEledon Pharmaceuticals Reports Third Quarter 2022 Operating and Financial Results
finance.yahoo.com - November 15 at 4:40 AM
Get Eledon Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for ELDN and its competitors with MarketBeat's FREE daily newsletter.



ELDN Media Mentions By Week

ELDN Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

ELDN
News Sentiment

0.89

0.77

Average
Medical
News Sentiment

ELDN News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

ELDN Articles
This Week

3

1

ELDN Articles
Average Week

Get Eledon Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for ELDN and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:ELDN) was last updated on 12/3/2023 by MarketBeat.com Staff

My Account -